CFLAR and cancer: To date, some mechanisms by which cancer cells developed resistance to TRAIL have been elucidated, including the dysfunction of DR4 or DR5, defects in FADD and the overexpression of anti-apoptotic proteins such as c-FLIP, Bcl-2 and Survivin [27].